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Objective: This study aimed to develop a pathway to bring together current UK legislation, good clinical
practice and appropriate management strategies that could be applied across a range of healthcare settings.
Methods: The pathway was constructed by a multidisciplinary clinical team based in a busy Memory
Assessment Service. A process of successive iteration was used to develop the pathway, with input
and refinement provided via survey and small group meetings with individuals from a wide range of
regional clinical networks and diverse clinical backgrounds as well as discussion with mobility centres
and Forum of Mobility Centres, UK.
Results:We present a succinct clinical pathway for patients with dementia, which provides a decision-making
framework for how health professionals across a range of disciplines deal with patients with dementia
who drive.
Conclusions: By integrating the latest guidance from diverse roles within older people’s health services
and key experts in the field, the resulting pathway reflects up-to-date policy and encompasses differing per-
spectives and good practice. It is potentially a generalisable pathway that can be easily adaptable for use
internationally, by replacing UK legislation for local regulations. A limitation of this pathway is that it does
not address the concern of mild cognitive impairment and how this condition relates to driving safety.
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Introduction
Driving is increasingly an integral part of human life,
particularly in developed countries, providing auton-
omy and other psychosocial benefits (Hiscock et al.,
2002). Concurrent with economic development, the
number of drivers is increasing worldwide, and this
changing demographic is also mirrored by an increas-
ingly aged population who drive, particularly the
number of female older drivers. In the UK, at present,
78% of people older than 60 years and 54% of people
older than 70 years hold a current driving licence
(National Traffic Survey, 2009). Driving allows older
people greater freedom to access different aspects of
society. This is particularly important if they are
limited in their physical mobility or are socially
isolated, for example, in a rural community, where
public transport links may be sporadic (O’Neill,
2010). However, with age comes an increased risk of
dementia, and studies have demonstrated that those
with a diagnosis of dementia are at an increased risk
when driving (e.g. Man-Song-Hing et al., 2007). They
are more likely to become lost (Eby et al., 2012), travel
too slowly (Eby et al., 2012), not wear a seat belt (Eby
et al., 2012) and be involved in a collision (Breen et al.,
2007). In addition, they can present an elevated
accident risk (Breen et al., 2007; Marshall, 2008).
Driving risk increases, depending on disease severity
(Iverson et al., 2010).
In the UK, currently, 1 in 14 people older than
65 years and 1 in 6 people older than 80 years have a
diagnosis of dementia, and this is set to rise by 2025,
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to over one million people in the UK (Dementia UK,
2007). This demographic expansion in people with
dementia is worldwide, and it is likely that 115 million
people will be living with dementia by 2050 (World
Alzheimer Report, 2009). Therefore, increasingly, the
numbers of those with dementia who drive represent a
major and increasing problem. Specific challenges are
raised, which include the underdiagnosis of dementia
and consequently the lack of awareness of many people
who drive and their families without knowing they
have dementia. However, early diagnosis raises the
challenging question of whether a patient is fit to drive,
and there are several key areas to consider.
Is a patient with dementia safe to drive?
For the clinician, the task of determining whether a
patient with dementia has the ability to continue to
drive safely may be problematic. The on-road assess-
ment at an accredited mobility centre for drivers with
cognitive impairment, in the UK, is recognised by the
British Psychological Society (2001) as being the ‘gold
standard’ (Box 1), and the importance of the on-road
assessment is further supported by old age psychia-
trists (Naidu and Mckeith, 2006) as being the most
popular suggestion as to how to address driving
ability. Areas of clarity do exist; for example, patients
with moderate to severe dementia are not fit to drive,
and many patients with dementia surrender their
licence voluntarily. However, there is no clear definition
of early or mild dementia, although Iverson et al. (2010)
do make a suggestion to deal with this, for example,
using the Clinical Dementia Rating Scale, caregivers’
rating of driving ability, a history of crashes, reduced
mileage and a mini-mental state examination of <24
to identify patients who are at increased risk of unsafe
driving. Also, fitness to drive should be based not only
on dementia severity alone but also on other relevant
factors such as vision, hearing, head turning ability
and daytime sleepiness (Mosimann et al., 2012), which
either may associate with dementia or be independent
from it or indeed synergistically act with the cognitive
impairment to affect driving ability. Many studies have
investigated the role that neuropsychological testing
has in evaluating an individual’s safety to drive. It has
been variously reported that a general cognitive test
battery (e.g. Dawson et al., 2009; Lincoln et al., 2010),
selective attention tasks (e.g. Ducheck et al., 1997), maze
test performance (e.g. Ott et al., 2003) and visuospatial
tasks (e.g. Silva et al., 2009) can be utilised to either
predict safe driving behaviour or be used to supplement
the clinician’s judgement. However, numerous studies
refute the efficacy of cognitive testing as a measure of
driving ability (e.g. Bieliauskas et al., 1998; Brown and
Ott, 2004; Molnar et al., 2006), and as no consensus
has been reached in this area, it is not possible to offer de-
finitive guidance to the clinician on what neuropsycho-
logical tests are best in this regard. Nevertheless, given
that an assessment of cognition and activities of daily
living are required when diagnosing dementia, this can
at least help to detect those with moderate to severe dis-
ease (Wagner et al., 2011) in whom the decision to advise
driving discontinuation is much more straightforward.
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The use of driving simulators, although an under-
researched area, may become a promising tool for
assessing fitness to drive in the future. A retrospective
study by Lee et al. (2003a, 2003b) indicated that individ-
uals at increased risk of a crash could be identified using
a PC-based driving simulator, while a comparison of a
simulator with an on-road test (Lee et al., 2003a,
2003b) has supported the validity of the driving simula-
tor. However, the availability of driving simulators is
not widespread, there are a large number of simulator
packages and no common standard, and assessment
using these requires additional expertise. In addition,
there can also be problems with simulator sickness
(Classen et al., 2011), which can present a challenge,
particularly in older drivers (Brooks et al., 2010).
Differing legislative requirements
In Europe, no specific citation is made of dementia
in the European directive (91/439/EEC) regarding
standards of mental and physical capability to drive
leading to differing interpretations between member
states (Breen et al., 2007). In the UK, patients are
required to inform the Driver and Vehicle Licensing
Agency (DVLA, 2011) when a diagnosis of dementia
is received, and physicians are recommended to report
to the DVLA those likely to continue driving despite
being advised not to when it is no longer safe. In
contrast, in the Netherlands, medical fitness to drive is
assessed at licence renewal or based on self-report from
the individual. If a dementia is reported to the licensing
authority, depending on disease severity and progres-
sion, patients can undergo examination from a neurol-
ogist/neuropsychologist and have an expert driving
assessment (CBR, 2000), and as an outcome from this,
they may be deemed temporarily suitable to retain their
licence, for usually not more than 5 years.
Outwith the EU, legislation is equally varied on how
of a diagnosis of dementia is reported to the appropri-
ate licensing authority. In Canada, for example, regu-
lations are state specific, and most states require
mandatory reporting of medically unfit drivers, al-
though dementia is not specifically mentioned (CMA
drivers guide, 2006). The US legislation also differs
from state to state but most do not require mandatory
reporting by clinicians (exceptions include, for
example, California, Pennsylvania, Delaware, Oregon,
Indiana, Arizona and New Mexico; with only
California and Pennsylvania specifically mentioning
Alzheimer’s disease) (Rapoport et al., 2007). Australia
requires the patient to inform the licensing authority
of any permanent long-term injury or illness that
affects safe driving ability, but again no specific men-
tion of dementia is made (Angley, 2001; Austroads,
2003). New Zealand only requires reporting if a pa-
tient is likely to continue driving after they have been
advised to cease (NZTA, 2009). However, all world-
wide legislation has a propensity to recommend that
a diagnosis of dementia alone is not adequate enough
to withdraw an individual’s licence to drive, but it of-
fers no guidance on what constitutes fitness to drive,
for those expected to make this recommendation.
Lack of guidance in how to deal with driving cessation
in dementia
Many patients who receive a diagnosis of dementia
continue to drive (Adler et al., 2005), with numbers
estimated at over 40% (Adler and Kuskowski, 2003),
and it has been reasoned that tackling the issue of driv-
ing and driving cessation should be a collaborative
process between the healthcare professional physician,
patients and their families (O’Neill, 2010). However,
family dynamics can make driving cessation problem-
atical. Relatives who rely on the patient for transport
in routine activities such as shopping, recreation and
childcare are more likely to continue their dependence
on the patient driving, despite impairment (Adler
et al., 2000a, 2000b), and so be less willing to work in
partnership with the physician (Adler et al., 2000a,
2000b). From a patient’s perspective, the cessation of
driving can also lead to a loss of independence (Adler
et al., 2000a, 2000b), increased dependence on family
members (Taylor and Tripodes, 2001) and/or a change
in living circumstances (Adler et al., 2000a, 2000b). The
loss of driving ability can lead to decreased life satisfac-
tion (Cutler, 1975) and increased isolation (Marottoli
et al., 2000) and depression (Ragland et al., 2005).
Crucially, patients and their families may often find that
there is little available in the way of viable alternatives
(e.g. Taylor and Tripodes, 2001; Arai et al., 2011).
Generally, given the onus is typically on clinical staff,
usually the physician, to make a judgement on the
patient’s competence to drive (Brown and Ott, 2004),
this can lead to a conflict between the patient and the
clinician with associated ramifications and effects on
the therapeutic alliance between patient and clinician.
A complicating factor is the need to not only make a
judgement at the initial stage of the therapeutic relation-
ship but also take a long-term outlook because of the
degenerative nature of dementia (O’Neill, 2010).
The lack of guidance and ambiguity in how to deal
with the issue of driving and the patient with dementia
may lead to a clinician’s reluctance to tackle the issue.
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Although key guidelines have been issued for dementia in
the UK and Europe (e.g. NICE, 2006; Hort et al. 2010 ),
these have failed to satisfactorily address the issue of driv-
ing, with these guidelines only briefly mentioning that
medicolegal issues including driving need to be addressed
but offering no supporting guidance for the clinician.
In summary, there is a great deal of uncertainty on how
patients with a dementia diagnosis, who wish to continue
to drive, should bemanaged. Hunter et al. (2009) support
the need for an objective way of dealing with the issue and
advises that a ‘co-operative approach between the clinical
team responsible for the person’s on-going care and a
driving assessment team is the best way of dealing with
difficult issues in this range of diseases’.
No real consensus exists on how cases should be
handled at either local or national level, and many
NHS trusts are now recognising the urgent need to
develop driving and dementia protocols. However,
although there exists some literature addressing fitness
to drive in dementia (e.g. Mosimann et al., 2012;
Iverson et al., 2010) and a “toolkit” guide developed
in Canada (Dementia network of Ottawa, 1997), there
is no generally accepted care pathway to guide clinicians
and people with dementia.
Therefore, our aim was to provide a pathway that
offered clarity in managing patients with dementia
who drive, with a secondary aim of improving road
safety and enabling those who are safe to drive to
continue to do so. We report the development of such
a pathway (Figure 1) in the UK—the purpose of which
was to bring together current UK legislation, good
clinical practice and appropriate management aspects
into a simple pathway that could be rapidly and easily
applied across a range of healthcare settings and also
be utilised by individuals with limited experience of
managing this issue.
Method
The pathway was initially constructed within an
experienced multidisciplinary clinical team in a busy
Memory Assessment Service (comprising a professor
of old age psychiatry, two senior clinical academics,
an experienced clinical psychologist and an assistant
psychologist). A process of successive iteration, and
consensual discussion within the group, developed a
draft pathway. Once the initial pathway had been
Figure 1 Driving pathway for patients with dementia (available to download from http://research.ncl.ac.uk/driving_and_dementia).
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drafted, a survey (respondents were asked to provide
ratings for the utility of the pathway, how likely they
would be to use it in practice and how much it
clarified the issue for them, as well as provide sugges-
tions for alterations or inclusion) of individuals, with
29 respondents, from a wide range of regional networks
(the North East Regional Old Age Psychiatry Network,
the North East branch of Psychology Specialists working
with Older People, North East branch of Psychology
Specialists working with Older People—Neuro-Special
Interest Group and the Newcastle and South Tyneside
Older Adult Community Mental Health Team) and
diverse clinical backgrounds (medicine and psychiatry
(15), nursing ( 4), psychology (8) and occupational
therapy (2)) helped refine the pathway. Participants
were asked to provide ratings for the utility of the
pathway, how likely they would be to use it in practice
and how much it clarified the issue for them, as well
as provide suggestions for alterations or specific inclu-
sions. Finally, the pathway was further shaped following
discussion with key external stakeholders, that is, North
East Drive Mobility (the Accredited Mobility Centre in
the North East of England), the UK Forum of Mobility
Centres and the Driver and Vehicle Licensing Agency,
into its final format.
Results
The pathway
The completed pathway (Figure 1) consists of a logically
ordered flow diagram, which is colour coded for ease of
use. It provides a step-by-step process to guide the user
through possible pathways an individual clinician may
take, beginning with their diagnosis and initial discus-
sion relating to driving. The user is then guided through
steps to take if there are concerns regarding the individ-
ual’s ability to drive. If the patient decides to cease
driving, the user is guided to the appropriate legal and
supportive actions to take. If the patient decides to
continue driving, the user is directed to an appropriate
course of action via the pathway, which is communi-
cated to the person and, if appropriate, their family.
The successive stages then channel the user through
the relevant clinical and legal procedures, in a logical
progression, pending the outcome of the DVLA
decision-making process.
It should be recognised, however, that this pathway
is not presented as a stand-alone item, but it is the
central aspect of an overall support package that was
developed by the aforementioned team. The full
‘driving pack’ contents are presented and described
in Table 1 (full pack available to download from
http://research.ncl.ac.uk/driving_and_dementia).
Discussion
We present a clinical pathway for patients with
dementia, which was developed following a robust
process with input from key experts in the field. The
overall aim was to address the uncertainty that exists
on how patients with a dementia diagnosis, who wish
to continue to drive, should be managed. By this
process, we have drawn together current UK legislation,
good clinical practice and appropriate management
aspects into a simple care pathway that could be rapidly
and easily applied across a range of healthcare settings
and also be utilised by individuals with limited experi-
ence of managing this issue.
A range of clinical pathways are available through
the National Institute for Health and Care Excellence
and bring together clinical guidelines, interventional
procedures, public health guidance and quality stan-
dards into a logical flow diagram for users (NICE,
2011). Pathways are accessible for a range of issues,
from blood disorders to mental health. A dementia
pathway has been established (NICE, 2011), and
although this is a generalised pathway, the driving
and dementia pathway would complement this, for
Table 1 Contents of driving pack
Content Description
Introduction
to pack
A leaflet informing the user on the contents
of the pack and guidance on use
The pathway A copy of the pathway itself
Patient information
leaflet
Gives guidance for the patient and
answers common questions around the
process and offers support and guidance
for alternative methods of transport
DVLA guidance Official guidelines from the DVLA on the
process of reporting a diagnosis
Local mobility leaflet Gives information from the local drive
mobility centre on what services can
be offered
Template letter A template letter for use by clinicians
and patients to inform the DVLA of a
diagnosis
Discussion guidance A template sheet offering guidance
questions that can be asked of the patient
and family, to guide discussion around
the issue
DVLA CG1 form DVLA medical information form for
patients to complete, giving details of
medical condition
DVLA surrender of
licence form
Form for patients to complete and return
to the DVLA if they decide to surrender
their licence
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example, by fitting into, promoting independence and
maintaining function section.
A strength of this pathway is the multidisciplinary
approach utilised in its development. The developers
were able to integrate the latest guidance from diverse
roles within older people’s service and key experts in
the field, resulting in a pathway that reflects up-to-date
policy and encompasses differing perspectives and
good practice. This procedure enhances the efficacy
of the pathway as a general tool that can be utilised
across all disciplines within service.
The pathway also provides the framework for a
uniform approach across services, as the pathway is
not a stand-alone tool. It forms part of a driving pack,
that contains further information and scaffolds the
pathway, for example, information on local mobility
centres; and alternative forms of transport, and is
supported by relevant patient information on pre
and post driving cessation advice. It is hoped that
this can facilitate discussion with patients and
families and enhance a collaborative approach
(O’Neill, 2010), between clinician, patient and family
when discussing the process of continuing to and
eventual cessation of driving. The use of the pathway
as part of a driving pack will also serve to normalise
the process of dealing with driving in the clinical
setting, as an on-going aspect of management of the
disease (Adler et al., 2000a, 2000b), and aid in addressing
the issue of viable alternatives (Taylor and Tripodes,
2001; Arai et al., 2011).
This pathway was developed in the UK, taking into
account UK practice and legislation; however, it
is potentially a generalised pathway that can be
easily adaptable for use worldwide, by substituting
UK-based (DVLA) legislation for local regulations.
The multidisciplinary method utilised in development
enables it to be integrated into differing service
approaches, internationally. This may also facilitate in
addressing the lack of guidance and clarification that
emerged, when investigating European, American,
Australian and New Zealand policy.
Particular limitations emerged during the develop-
ment of this pathway. The first is that in the area of
driving and dementia, there is a lack of coherency in
the field in terms of theory and empirical evidence,
and thus, our pathway is informed on the basis of
expert clinical judgement and consensus opinion.
And although we recognise this is not as strong as
empirical evidence, it was ratified by a range of
respondents as clinically useful. However, where pos-
sible, the advice given is based upon previous research
(e.g. Chu (1994) found that older drivers do report
that driving at night and at peak hours is more
problematical for them. Also, reduced crash rates for
older drivers at evenings and weekends (Stutts and
Martell, 1992) suggest that older drivers avoid
driving at these times, so it would be reasonable to
suppose that advising a reduction in these behav-
iours would reduce risk). Therefore, an important
next step in implementing the pathway into practice
would be to carry out formal service evaluations to
test the utility of the pathway and compare it with
usual practice. Also, in our consultation process, a
number of participants expressed the desire for a
definitive neuropsychological domain that can be
tested, or a cognitive test battery that can be utilised,
to determine an individual’s ability to drive.
However, the evidence base for this is lacking, and
the use of neuropsychological testing for this
purpose remains a controversial area, with no con-
sensus reached on what areas or tests are particularly
useful. Which neuropsychological domains correlate
with drive ability is an area for further research,
and the development of a short test battery, which
can be used in clinic, would be apposite and useful
in addressing immediate concerns. In particular,
with the increasing availability of technology, the
utility of driving simulation shows promise as a
relevant tool and would be a useful area for explora-
tion although access and cost may be major barriers.
Our pathway does not seek to determine the driving
ability of patients but to offer best practice guidance
to clinicians and clarification on the issues surround-
ing driving with dementia.
A further potential limitation of this pathway is that it
does not address the concern of mild cognitive impair-
ment (MCI) (Budson and Solomon, 2012; Petersen,
2004) and how this condition relates to driving safety.
The diagnosis of MCI remains a contentious area,
because the label is not necessarily indicative of an
underlying neurodegenerative process. Furthermore,
it seeks to medicalise a mild impairment, which is
defined as having little or no functional impact.
Importantly, people in receipt of this diagnosis may
not experience any further decline or necessarily prog-
ress to a dementia (Whitehouse and Moody, 2006),
and some may revert to normal cognitive function on
reassessment (Koepsell and Monsell, 2012). Thus, it
may be inappropriate to label such individuals medi-
cally and potentially from a legislative perspective, as
impaired, with regard to driving. Current guidance,
practice and legislation are not sufficient in providing a
clarified and unified approach managing this controver-
sial question. Further work is needed in this area, with
next steps being the production of a pathway to provide
clarity and best practice surrounding those with MCI.
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